Silicon Valley Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Silicon Valley Capital Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64K	Hold	62	–	–	﹤0.01%	308
2025 Q4	$1.79K	Hold	62	–	–	﹤0.01%	246
2025 Q3	$1.72K	Hold	62	–	–	﹤0.01%	264
2025 Q2	$1.51K	Hold	62	–	–	﹤0.01%	285
2025 Q1	$1.33K	Hold	62	–	–	﹤0.01%	230
2024 Q4	$1.46K	Hold	62	–	–	﹤0.01%	299
2024 Q3	$1.58K	Hold	62	–	–	﹤0.01%	294
2024 Q2	$1.45K	Hold	62	–	–	﹤0.01%	292
2024 Q1	$1.78K	Hold	62	–	–	﹤0.01%	282
2023 Q4	$2.03K	Hold	62	–	–	﹤0.01%	309
2023 Q3	$1.72K	Hold	62	–	–	﹤0.01%	264
2023 Q2	$2.11K	Hold	62	–	–	﹤0.01%	265
2023 Q1	$1.86K	Hold	62	–	–	﹤0.01%	209
2022 Q4	$1.75K	Buy	+62	New	+$1.97K	﹤0.01%	171

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Silicon Valley Capital Partners's ARKG Position: Q1 2026 in Review

Silicon Valley Capital Partners held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 62 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Silicon Valley Capital Partners first reported a position in ARKG in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.11K in Q2 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Silicon Valley Capital Partners held 62 shares of ARK Genomic Revolution ETF worth $1.64K as of Q1 2026.
Silicon Valley Capital Partners left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #308 holding.
Silicon Valley Capital Partners first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 14 quarters since.
Silicon Valley Capital Partners's ARK Genomic Revolution ETF position peaked at $2.11K in Q2 2023.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.